Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100417652 | 10041765 | 2 | F | 20130125 | 20150317 | 20140327 | 20150331 | EXP | SE-MPA-2014-001864 | SE-WATSON-2014-05487 | WATSON | 74.00 | YR | M | Y | 0.00000 | 20150331 | N | CN | SE | SE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100417652 | 10041765 | 1 | PS | Litarex | LITHIUM CITRATE | 1 | ORAL | UNK (^3 ST^) | D | UNKNOWN | 0 | PROLONGED-RELEASE TABLET | |||||||
| 100417652 | 10041765 | 2 | SS | Zopiclone (Unknown) | ZOPICLONE | 1 | ORAL | 15 MG, UNK | D | UNCONFIRMED | 0 | 15 | MG | UNK | |||||
| 100417652 | 10041765 | 3 | SS | Olanzapine (Unknown) | OLANZAPINE | 1 | ORAL | 10 MG, UNK | D | UNCONFIRMED | 0 | 10 | MG | UNK | |||||
| 100417652 | 10041765 | 4 | SS | Metoprolol (Unknown) | METOPROLOL | 1 | ORAL | 150 MG, UNK | D | UNCONFIRMED | 74217 | 150 | MG | UNK | |||||
| 100417652 | 10041765 | 5 | SS | Felodipine (Unknown) | FELODIPINE | 1 | ORAL | 15 MG, UNK | D | UNCONFIRMED | 0 | 15 | MG | UNK | |||||
| 100417652 | 10041765 | 6 | SS | TEGRETOL | CARBAMAZEPINE | 1 | ORAL | 1800 MG, UNK | D | 0 | 1800 | MG | |||||||
| 100417652 | 10041765 | 7 | SS | PROPAVAN | PROPIOMAZINE | 1 | ORAL | 75 MG, UNK | D | 0 | 75 | MG | TABLET | ||||||
| 100417652 | 10041765 | 8 | SS | ETALPHA | ALFACALCIDOL | 1 | ORAL | 075 MG, UNK | D | 0 | 75 | MG | |||||||
| 100417652 | 10041765 | 9 | SS | KALCIDON | CALCIUM CARBONATE | 1 | ORAL | 2250 MG, UNK | D | 0 | 2250 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 100417652 | 10041765 | 1 | Product used for unknown indication |
| 100417652 | 10041765 | 2 | Product used for unknown indication |
| 100417652 | 10041765 | 3 | Product used for unknown indication |
| 100417652 | 10041765 | 4 | Product used for unknown indication |
| 100417652 | 10041765 | 5 | Product used for unknown indication |
| 100417652 | 10041765 | 6 | Product used for unknown indication |
| 100417652 | 10041765 | 7 | Product used for unknown indication |
| 100417652 | 10041765 | 8 | Product used for unknown indication |
| 100417652 | 10041765 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 100417652 | 10041765 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 100417652 | 10041765 | Akathisia | |
| 100417652 | 10041765 | Metabolic acidosis | |
| 100417652 | 10041765 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 100417652 | 10041765 | 1 | 20130125 | 20130125 | 0 | |
| 100417652 | 10041765 | 2 | 20130125 | 20130125 | 0 | |
| 100417652 | 10041765 | 3 | 20130125 | 20130125 | 0 | |
| 100417652 | 10041765 | 4 | 20130125 | 20130125 | 0 | |
| 100417652 | 10041765 | 5 | 20130125 | 20130125 | 0 | |
| 100417652 | 10041765 | 6 | 20130125 | 20130125 | 0 | |
| 100417652 | 10041765 | 7 | 20130125 | 20130125 | 0 | |
| 100417652 | 10041765 | 8 | 20130125 | 20130125 | 0 | |
| 100417652 | 10041765 | 9 | 20130125 | 20130125 | 0 |